Beryl Drugs Limited (BOM:524606)

Market Cap	111.32M -38.2%
Revenue (ttm)	176.65M -12.3%
Net Income	141.00K -82.3%
EPS	0.03 -83.1%
Shares Out	5.07M
PE Ratio	789.53
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	315
Average Volume	1,924
Open	21.88
Previous Close	21.88
Day's Range	21.11 - 22.50
52-Week Range	17.35 - 34.19
Beta	-0.02
RSI	48.05
Earnings Date	Feb 9, 2026

About Beryl Drugs

Beryl Drugs Limited manufactures and markets pharmaceutical products in India. The company offers various branded and generic pharmaceutical formulations, bulk drugs, I.V. fluids, small volume injectables in liquid and dry powder forms, and eye and ear drops, as well as veterinary products. It also provides research and development, and contract manufacturing services. The company exports its products. Beryl Drugs Limited was incorporated in 1993 and is based in Indore, India.

• Industry: Pharmaceutical Preparations
• Founded: 1993
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524606

Financial Performance

In fiscal year 2025, Beryl Drugs's revenue was 211.46 million, a decrease of -20.89% compared to the previous year's 267.30 million. Earnings were 5.79 million, a decrease of -24.69%.